Skip to main content
. 2019 Mar 12;13:791–805. doi: 10.2147/DDDT.S170913

Table S1.

AE profiles of CMAB008 and Remicade

Multiple-dose group CMAB008
Multiple-dose group Remicade31
3 mg/kg (n=9) 1, 3, 10 mg/kg (n=87)
Any AE 4 46
Rash 0 6
Headache 0 11
Pharyngitis 0 6
Rhinitis 0 6
Diarrhea 0 8
Cough 0 5
Nausea 1 0
Upper respiratory tract infection 0 4
Urinary tract infection 0 0
RBC decrease 1 0
WBC decrease 1 0
Hb decrease 1 0
SAE 0 5

Abbreviations: AE, adverse event; RBC, red blood cell; SAE, serious AE; WBC, white blood cell.